SLG
ALNY icon

Stanley-Laman Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Stanley-Laman Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,023
Closed -$219K – 266
2019
Q2 		$219K Buy
+3,023
New +$232K 0.05% 263
2019
Q1 		– Sell
-2,875
Closed -$210K – 259
2018
Q4 		$210K Buy
+2,875
New +$221K 0.06% 238
2015
Q3 		– Sell
-3,000
Closed -$360K – 322
2015
Q2 		$360K Hold
3,000
– – 0.07% 235
2015
Q1 		$313K Hold
3,000
– – 0.06% 248
2014
Q4 		$291K Hold
3,000
– – 0.06% 265
2014
Q3 		$234K Buy
+3,000
New +$194K 0.05% 262
2014
Q2 		– Sell
-3,000
Closed -$201K – 291
2014
Q1 		$201K Buy
+3,000
New +$232K 0.04% 308

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return